Boenning & Scattergood’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $301K | Sell |
2,311
-1,850
| -44% | -$241K | 0.05% | 323 |
|
|
2022
Q3 | $487K | Buy |
4,161
+160
| +4% | +$18.7K | 0.1% | 228 |
|
|
2022
Q2 | $471K | Buy |
4,001
+1,690
| +73% | +$199K | 0.09% | 230 |
|
|
2022
Q1 | $301K | Sell |
2,311
-121
| -5% | -$15.8K | 0.05% | 323 |
|
|
2021
Q4 | $371K | Sell |
2,432
-47
| -2% | -$7.17K | 0.06% | 294 |
|
|
2021
Q3 | $400K | Buy |
2,479
+145
| +6% | +$23.4K | 0.07% | 270 |
|
|
2021
Q2 | $382K | Buy |
2,334
+105
| +5% | +$17.2K | 0.07% | 272 |
|
|
2021
Q1 | $336K | Buy |
2,229
+375
| +20% | +$56.5K | 0.06% | 278 |
|
|
2020
Q4 | $281K | Sell |
1,854
-30
| -2% | -$4.55K | 0.06% | 283 |
|
|
2020
Q3 | $255K | Buy |
+1,884
| New | +$255K | 0.06% | 275 |
|
|
2019
Q1 | – | Sell |
-11,674
| Closed | -$1.13M | – | 282 |
|
|
2018
Q4 | $1.13M | Buy |
+11,674
| New | +$1.13M | 0.39% | 74 |
|